Merck & Co., Inc. (MRK): A Bull Case Theory

Yahoo Finance15:18 ET

Merck & Co's Options: A Look at What the Big Money Is Thinking

Benzinga15:02 ET

Green Gives Way to Red on Gossamer Macro Expectations: Live Stock News

Kevin TraversMar 18 10:32 ET

Actinium Pharmaceuticals Launches Clinical Program to Evaluate Actimab-A as Combination Cancer Therapy

MT NewswiresMar 18 08:37 ET

Express News | Actinium Pharmaceuticals Announces A Clinical Trial Program For Solid Tumors Combining Actimab-A With PD-1 Checkpoint Inhibitors KEYTRUDA And OPDIVO; Clinical Proof Of Concept Data Expected In 2025

BenzingaMar 18 08:13 ET

Is Merck & Co., Inc.'s (NYSE:MRK) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Simply Wall StMar 18 07:24 ET